천식 치료제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 종류별, 제품별(흡입기, 네블라이저), 투여 경로별, 지역별, 경쟁별(2020-2030년)
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Product (Inhalers, Nebulizers), By Route of Administration, By Region and Competition, 2020-2030F
상품코드:1881573
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 천식 치료제 시장은 2024년 275억 2,000만 달러에서 2030년까지 343억 달러로, CAGR 3.74%로 성장할 것으로 예측됩니다.
천식 치료제는 기도의 염증과 협착을 특징으로 하는 만성 호흡기질환인 천식 증상을 관리하고 완화하기 위해 고안된 다양한 의약품 및 치료법을 포함합니다. 시장 성장은 주로 천식, 특히 도시화 지역에서 천식 유병률의 증가와 질병 관리에 대한 인식이 높아짐에 따라 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
275억 2,000만 달러
시장 규모 : 2030년
343억 달러
CAGR : 2025-2030년
3.74%
가장 빠르게 성장하는 부문
병용요법
최대 시장
북미
주요 시장 촉진요인
전 세계 천식 환자의 증가는 치료제 수요를 크게 증가시키고 있습니다. 전 세계적으로 만성 호흡기질환으로 진단받는 환자가 증가하고 있으며, 장기적인 관리와 다양한 치료적 개입이 필요한 질환입니다.
주요 시장 과제
첨단 생물학적 제제 요법에 따른 높은 비용은 세계 천식 치료제 시장에 큰 도전이 되고 있습니다. 이러한 높은 가격 설정은 환자의 치료 접근성에 직접적인 영향을 미치고 있으며, 특히 다양한 의료 서비스에서 상환 정책이나 개인의 경제력이 제한적인 요인이 될 수 있습니다.
주요 시장 동향
이러한 추세는 실시간 데이터와 복약 순응도 향상을 통해 천식 관리를 혁신적으로 변화시킬 것입니다. 센서가 장착된 디지털 건강 플랫폼과 스마트 흡입기는 사용 상황과 흡입 기술을 모니터링하여 치료 효과를 직접적으로 향상시킵니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 천식 치료제 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
약물 종류별(항염증제, 병용요법, 기관지확장제)
제품별(흡입기, 네블라이저)
투여 경로별(경구, 흡입, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 천식 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 천식 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 천식 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 천식 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 천식 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 천식 치료제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Teva Pharmaceutical Industries Ltd.
GSK plc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
AstraZeneca plc.
Boehringer Ingelheim International GmbH
Sanofi S.A.
Koninklijke Philips N.V.
Becton, Dickinson and Company
Sunovion Pharmaceuticals, Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Asthma Therapeutics Market will grow from USD 27.52 Billion in 2024 to USD 34.3 Billion by 2030 at a 3.74% CAGR. Asthma therapeutics encompass a range of pharmaceutical medications and treatment modalities designed to manage and alleviate the symptoms of asthma, a chronic respiratory condition characterized by airway inflammation and narrowing. The market's growth is primarily driven by the escalating global prevalence of asthma, particularly in urbanized regions, and the increasing awareness regarding disease management.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 27.52 Billion
Market Size 2030
USD 34.3 Billion
CAGR 2025-2030
3.74%
Fastest Growing Segment
Combination Therapy
Largest Market
North America
Key Market Drivers
The increasing global asthma prevalence significantly propels the demand for therapeutics. A growing number of individuals worldwide are diagnosed with this chronic respiratory condition, necessitating long-term management and various treatment interventions. This expanding patient population inherently broadens the market for existing medications and drives the need for new therapeutic developments. Factors such as urbanization, increased exposure to environmental allergens, and lifestyle changes contribute to the rising incidence of asthma across diverse demographics.
Key Market Challenges
The high cost associated with advanced biologic therapies represents a significant challenging factor for the global asthma therapeutics market. This elevated pricing directly impacts patient access, particularly in diverse healthcare systems where reimbursement policies or individual financial capacities may be restrictive. Consequently, a substantial portion of the patient population requiring these advanced treatments may face barriers to obtaining them, thereby limiting the overall market penetration and expansion of these innovative therapies.
Key Market Trends
This trend transforms asthma management via real-time data and enhanced medication adherence. Digital health platforms and smart inhalers, with sensors, monitor usage and technique, directly improving treatment efficacy. Over 35 million people in the U.S. lived with a chronic lung condition in 2023, as reported by the American Lung Association in September 2024, highlighting the need for these solutions. Such integration enables personalized adjustments and better patient-provider communication. For example, Adherium announced in April 2024 that its Hailie Smartinhaler received FDA clearance for AstraZeneca's Airsupra and Breztri inhalers, providing real-time medication usage insights. These advancements drive demand for technologically integrated therapeutics.
Key Market Players
Teva Pharmaceutical Industries Ltd.
GSK plc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
AstraZeneca plc.
Boehringer Ingelheim International GmbH
Sanofi S.A.
Koninklijke Philips N.V.
Becton, Dickinson and Company
Sunovion Pharmaceuticals, Inc.
Report Scope:
In this report, the Global Asthma Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Asthma Therapeutics Market, By Drug Class:
Anti-inflammatory
Combination Therapy
Bronchodilators
Asthma Therapeutics Market, By Product:
Inhalers
Nebulizers
Asthma Therapeutics Market, By Route of Administration:
Oral
Inhaled
Others
Asthma Therapeutics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Asthma Therapeutics Market.
Available Customizations:
Global Asthma Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Asthma Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Anti-inflammatory, Combination Therapy, Bronchodilators)
5.2.2. By Product (Inhalers, Nebulizers)
5.2.3. By Route of Administration (Oral, Inhaled, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Asthma Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Product
6.2.3. By Route of Administration
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Asthma Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Product
6.3.1.2.3. By Route of Administration
6.3.2. Canada Asthma Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Product
6.3.2.2.3. By Route of Administration
6.3.3. Mexico Asthma Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Product
6.3.3.2.3. By Route of Administration
7. Europe Asthma Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Product
7.2.3. By Route of Administration
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Asthma Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Product
7.3.1.2.3. By Route of Administration
7.3.2. France Asthma Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Product
7.3.2.2.3. By Route of Administration
7.3.3. United Kingdom Asthma Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Product
7.3.3.2.3. By Route of Administration
7.3.4. Italy Asthma Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Product
7.3.4.2.3. By Route of Administration
7.3.5. Spain Asthma Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Product
7.3.5.2.3. By Route of Administration
8. Asia Pacific Asthma Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Product
8.2.3. By Route of Administration
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Asthma Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Product
8.3.1.2.3. By Route of Administration
8.3.2. India Asthma Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Product
8.3.2.2.3. By Route of Administration
8.3.3. Japan Asthma Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Product
8.3.3.2.3. By Route of Administration
8.3.4. South Korea Asthma Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Product
8.3.4.2.3. By Route of Administration
8.3.5. Australia Asthma Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Product
8.3.5.2.3. By Route of Administration
9. Middle East & Africa Asthma Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Product
9.2.3. By Route of Administration
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Asthma Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Product
9.3.1.2.3. By Route of Administration
9.3.2. UAE Asthma Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Product
9.3.2.2.3. By Route of Administration
9.3.3. South Africa Asthma Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Product
9.3.3.2.3. By Route of Administration
10. South America Asthma Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Product
10.2.3. By Route of Administration
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Asthma Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Product
10.3.1.2.3. By Route of Administration
10.3.2. Colombia Asthma Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Product
10.3.2.2.3. By Route of Administration
10.3.3. Argentina Asthma Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Product
10.3.3.2.3. By Route of Administration
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Asthma Therapeutics Market: SWOT Analysis
